SCHEMBL1721052

SCHEMBL1721052

CC(C)OC(=O)N1CCC(OCCC(=O)O)CC1

nearest known ligand 0.44

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 17/20 0.44
FAAH O00519 1/20 0.40
MMP1 P03956 1/20 0.35
MMP3 P08254 1/20 0.35
MMP7 P09237 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
P2RY12 Q9H244 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1721381 0.87 GPR119 (0.43) GPR119FAAH
SCHEMBL15835945 0.85 GPR119 (0.46) GPR119FAAH
SCHEMBL1721777 0.85 CHRNB2 (0.38) GPR119FAAHP2RY12
SCHEMBL865374 0.85 ITGB3 (0.46) GPR119FAAH
SCHEMBL28870297 0.81 GPR119 (0.50) GPR119FAAHMMP1MMP3MMP7
SCHEMBL611473 0.80 GPR119 (0.42) GPR119FAAH
SCHEMBL4035282 0.79 HPGD (0.48) GPR119
SCHEMBL13677270 0.79 GPR119 (0.46) GPR119FAAH
SCHEMBL26209372 0.78 HRH3 (0.38)
SCHEMBL13676902 0.78 GPR119 (0.45) GPR119FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406256-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Prosidion Limited (GB) 2012-01-18 EP disclosed
WO-2010103335-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed